Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
611.09
744.86
658.41
467.17
362.93
413.46
396.78
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
611.09
744.86
658.41
467.17
362.93
413.46
396.78
Raw Material Cost
163.40
147.54
142.76
101.50
53.26
59.30
55.55
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
58.86
64.62
66.01
57.30
57.21
57.81
71.98
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.23
4.50
4.47
4.92
4.83
4.17
5.23
Selling and Distribution Expenses
127.72
124.25
161.38
125.66
136.66
124.91
129.31
Other Expenses
14.03
70.43
12.21
15.56
11.17
13.24
11.01
Total Expenditure (Excl Depreciation)
495.51
1,045.24
496.73
444.98
363.63
378.56
372.16
Operating Profit (PBDIT) excl Other Income
115.60000000000001
-300.4
161.70000000000002
22.200000000000003
-0.7000000000000001
34.900000000000006
24.6
Other Income
6.57
12.10
13.81
15.19
19.11
20.81
23.48
Operating Profit (PBDIT)
137.01
-274.38
189.82
51.52
31.14
68.41
63.34
Interest
5.23
4.50
4.47
4.92
4.83
4.17
5.23
Exceptional Items
36.72
-90.73
0.73
1.53
0.00
-10.10
-2.50
Gross Profit (PBDT)
447.69
597.31
515.65
365.68
309.67
354.16
341.23
Depreciation
14.86
13.91
14.33
14.13
12.73
12.70
15.23
Profit Before Tax
153.64
-383.52
171.74
34.01
13.58
41.45
40.37
Tax
-43.25
63.99
12.69
0.40
7.12
5.33
-5.28
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
196.89
-447.51
159.05
33.61
6.46
36.12
45.66
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
196.89
-447.51
159.05
33.61
6.46
36.12
45.66
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
196.89
-447.51
159.05
33.61
6.46
36.12
45.66
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,357.38
1,142.72
1,527.74
1,221.07
1,077.07
961.19
859.34
Earnings per share (EPS)
1.89
-4.6
1.61
0.34
0.07
0.36
0.43
Diluted Earnings per share
1.89
-4.6
1.61
0.34
0.07
0.36
0.43
Operating Profit Margin (Excl OI)
18.91%
-40.33%
24.56%
4.75%
-0.19%
8.44%
6.21%
Gross Profit Margin
27.57%
-49.62%
28.26%
10.3%
7.25%
13.1%
14.01%
PAT Margin
32.22%
-60.08%
24.16%
7.19%
1.78%
8.74%
11.51%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 68.39% vs 38.94% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 2,929.23% vs 127.20% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 986.67% vs 110.08% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 8.33% vs -7.69% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Sarepta Therapeutics, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
611.09
578.66
32.43
5.60%
Other Operating Income
0.00
0.00
0.00
Total Operating income
611.09
578.66
32.43
5.60%
Raw Material Cost
163.40
0.00
163.40
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
58.86
0.00
58.86
Power Cost
0
0
0.00
Manufacturing Expenses
5.23
68.67
-63.44
-92.38%
Selling and Distribution Expenses
127.72
272.30
-144.58
-53.10%
Other Expenses
14.03
23.18
-9.15
-39.47%
Total Expenditure (Excl Depreciation)
495.51
572.80
-77.29
-13.49%
Operating Profit (PBDIT) excl Other Income
115.58
5.86
109.72
1,872.35%
Other Income
6.57
9.48
-2.91
-30.70%
Operating Profit (PBDIT)
137.01
219.28
-82.27
-37.52%
Interest
5.23
68.67
-63.44
-92.38%
Exceptional Items
36.72
-59.97
96.69
161.23%
Gross Profit (PBDT)
447.69
0.00
447.69
Depreciation
14.86
0.00
14.86
Profit Before Tax
153.64
90.64
63.00
69.51%
Tax
-43.25
0.00
-43.25
Provisions and contingencies
0
0
0.00
Profit After Tax
196.89
30.18
166.71
552.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
196.89
30.18
166.71
552.39%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
60.46
-60.46
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
196.89
90.64
106.25
117.22%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,357.38
6,347.91
-4,990.53
-78.62%
Earnings per share (EPS)
1.89
0.07
1.82
2,600.00%
Diluted Earnings per share
1.89
0.07
1.82
2,600.00%
Operating Profit Margin (Excl OI)
18.91%
36.26%
0.00
-17.35%
Gross Profit Margin
27.57%
15.66%
0.00
11.91%
PAT Margin
32.22%
5.21%
0.00
27.01%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 61.11 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is -17.96% vs 13.14% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 68.39% vs 38.94% in Jun 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 19.69 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 144.00% vs -381.45% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 2,929.23% vs 127.20% in Jun 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.04 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 145.51% vs -262.78% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 986.67% vs 110.08% in Jun 2024
Quarterly - Interest
Interest 0.52 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 15.56% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 8.33% vs -7.69% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.91%
in Jun 2025Figures in %
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
